REVIEW article
Front. Cell Dev. Biol.
Sec. Cancer Cell Biology
This article is part of the Research TopicExploring the Tumor Microenvironment: From Immune Dynamics to Therapeutic OpportunitiesView all 5 articles
The Interplay between Exosomal miRNAs and Cytokine Networks in Metabolic Diseases
Provisionally accepted
- 1Department of Pharmacy, Banasthali Vidyapith, Jaipur, India
- 2LSU Health Shreveport School of Medicine, Shreveport, United States
- 3Dr. Dayaram Patel Pharmacy College, Bardoli, India
- 4Maharishi Markandeshwar (Deemed to be University), Mullana, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract Exosomal microRNAs (miRNAs) are increasingly recognized as central regulators of metabolic pathways, influencing glucose homeostasis, lipid metabolism, and inflammatory responses. Their ability to mediate inter-organ communication positions them as both biomarkers and therapeutic candidates for metabolic diseases such as type 2 diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). This review synthesizes recent literature on the mechanistic roles of exosomal miRNAs in metabolic regulation, their influence on insulin sensitivity and lipid homeostasis, and their interaction with cytokine networks. It also evaluates current approaches in exosome engineering, including miRNA enrichment, surface modification, and CRISPR/Cas9-based editing, as well as emerging high-throughput technologies for profiling exosomal miRNAs. Exosomal miRNAs modulate insulin signaling, lipid catabolism, adipogenesis, and inflammatory responses, thereby contributing to metabolic adaptation and disease progression. Specific miRNAs, such as miR-122, miR-155, and miR-34a, have been implicated in obesity, diabetes, and NAFLD, serving as both biomarkers and therapeutic targets. Advances in exosome engineering and delivery strategies have demonstrated improved specificity, stability, and therapeutic efficacy. High-throughput sequencing and single-vesicle analyses provide insights into the heterogeneity and dynamics of exosomal miRNAs, supporting their clinical translation. Exosomal miRNAs represent promising tools for diagnosis and therapy in metabolic disorders. Their dual role as regulators of metabolic processes and carriers of therapeutic cargo underscores their potential in precision medicine. Future integration of bioengineering, CRISPR-based modulation, and omics-driven predictive modeling will enhance their translational applicability, paving the way for personalized therapies in metabolic diseases.
Keywords: Bioengineering, biomarkers, exosomal miRNAs, Metabolic Regulation, Therapeutic delivery
Received: 23 Oct 2025; Accepted: 23 Jan 2026.
Copyright: © 2026 Joshi, Verma, Kapoor, Saini and Sharma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Devesh U Kapoor
Swapnil Sharma
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.